Haw Par Corporation sees a rise in net profit by 18.2% YoY in H1 2025
Haw Par Corporation reported an 18.2% year-on-year increase in net profit, reaching $144.1 million in H1 2025. Group revenue rose by 7% to $126.3 million, driven by strong demand for healthcare products. The gross margin improved from 54.6% to 56.5%. Other income increased by 20.3% to $116.8 million, attributed to higher dividends from investments. Earnings per share rose to 65.1 cents, and an interim dividend of 20 cents per share was declared, payable on 11 September.
Group revenue also increased by 7% in the same period.
Haw Par Corporation reported a net profit of $144.1m in the first half of 2025 (H1 2025), up by 18.2% year-on-year (YoY).
The group's revenue also rose by 7% to $126.3m, primarily due to the resilient demand for healthcare products.
The gross margin also improved from 54.6% to 56.5%, due to demand shifts of product segments from year to year.
Other income increased 20.3% to $116.8m, due to a higher dividend rate from strategic and long-term investments.
Haw Par's earnings per share stood at 65.1 cents for H1 2025, up from 55.1 cents recorded during the same period a year ago.
An interim dividend of 20 cents per share was declared for H1 2025, unchanged from the year before. The dividend will be paid on 11 September, after the books close on 21 August.
